MUMBAI, India, May 9 -- Intellectual Property India has published a patent application (202341075527 A) filed by Extrovis Ag; and Athyna Pharma Llc, Baar, Switzerland, on Nov. 6, 2023, for 'pharmaceutical compositions.'
Inventor(s) include Kirankumar Kowkuntla.
The application for the patent was published on May 9, under issue no. 19/2025.
According to the abstract released by the Intellectual Property India: "The present disclosure relates to a stable, fast-disintegrating pharmaceutical tablet for buccal or sublingual administration, containing buprenorphine or its pharmaceutically acceptable salt, and naloxone or its pharmaceutically acceptable salt, providing enhanced ease of administration. The stable pharmaceutical tablet disintegra...